Home › Kanser (lahat ng uri) › Texas › San Antonio
Pag-aaral pangklinika para sa Kanser (lahat ng uri) sa San Antonio, TX
Isang pag-aaral para sa Kanser (lahat ng uri) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa San Antonio. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of ASP3082 in Adults With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology, San Antonio
A Study of PHN-012 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1
- PHN-012-001 Site, San Antonio
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Nagre-recruitPhase 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Nagre-recruitPhase 2
- Mays Cancer Center ( Site 0039), San Antonio
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology, San Antonio
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- GSK Investigational Site, San Antonio
Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
Nagre-recruitPhase 1
- NEXT Oncology ( Site 0151), San Antonio
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
Nagre-recruitPhase 3
- START San Antonio ( Site 0104), San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Nagre-recruitPhase 2/3
- Sam Clinical Research Center, San Antonio
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
Nagre-recruitPhase 1/2
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology, San Antonio
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Nagre-recruitPhase 3
- Texas Oncology-San Antonio Cancer Care, San Antonio
- Texas Oncology - San Antonio Northeast, San Antonio
- Texas Oncology - San Antonio Stone Oak, San Antonio
Prostate Active Surveillance Study
Nagre-recruitObservasyonal na pag-aaral
- University of Texas Health Science Center, San Antonio, San Antonio
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Nagre-recruitPhase 1
- NEXT Oncology, San Antonio
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Children's Hospital of San Antonio, San Antonio
- Methodist Children's Hospital of South Texas, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Nagre-recruitPhase 1/2
- Site 01, San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Nagre-recruitPhase 1
- NEXT Oncology San Antonio, San Antonio
- START- San Antonio, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- UT Health Mays Cancer Center, San Antonio
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Nagre-recruitPhase 1
- NEXT Oncology, San Antonio
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
Nagre-recruitPhase 1
- START San Antonio, San Antonio
IDOV-Immune for Advanced Solid Tumors
Nagre-recruitPhase 1
- South Texas Accelerated Research Therapeutics, San Antonio
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Nagre-recruitPhase 3
- Texas Oncology San Antonio Medical Center, San Antonio
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- START San Antonio, LLC., San Antonio
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology, San Antonio
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Nagre-recruitPhase 1
- USA Clinical Trials, San Antonio
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- START San Antonio, San Antonio
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- START, San Antonio
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Nagre-recruitPhase 1
- Context Investigational Site, San Antonio
- Context Investigational Site, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Nagre-recruitPhase 1
- Research Site #2, San Antonio
- Research Site, San Antonio
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Nagre-recruitPhase 1
- GSK Investigational Site, San Antonio
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Nagre-recruitPhase 1/2
- NEXT Oncology, San Antonio
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT San Antonio, San Antonio
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology San Antonio, San Antonio
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
Nagre-recruitPhase 1
- UT Health, San Antonio
A Study of YL242 in Subjects With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- US-207, San Antonio
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Nagre-recruitPhase 1
- NEXT Oncology, San Antonio
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
Nagre-recruitPhase 1
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Nagre-recruitPhase 1/2
- NEXT Oncology, San Antonio
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Nagre-recruit
- University of Texas Health Science Center at San Antonio, San Antonio
Pag-aaral para sa Kanser (lahat ng uri) sa ibang lungsod
- Houston, TX121 pag-aaral
- New York City, NY109 pag-aaral
- Boston, MA85 pag-aaral
- Los Angeles, CA74 pag-aaral
- Nashville, TN65 pag-aaral
- Philadelphia, PA59 pag-aaral
- Washington, DC58 pag-aaral
- Durham, NC58 pag-aaral
- Chicago, IL51 pag-aaral
- Atlanta, GA49 pag-aaral
- Seattle, WA49 pag-aaral
- Arlington, VA48 pag-aaral
Iba pang pag-aaral sa San Antonio
- Non-Small Cell Lung Cancer59 pag-aaral
- Kanser sa Suso47 pag-aaral
- Colorectal Cancer46 pag-aaral
- Metastatic Cancer44 pag-aaral
- Obesity40 pag-aaral
- Type 2 Diabetes37 pag-aaral
- Overweight34 pag-aaral
- Kanser sa Ovary31 pag-aaral
- Kanser sa Pancreas31 pag-aaral
- Kanser sa Prostate28 pag-aaral
- Kanser ng Endometrium27 pag-aaral
- Kanser sa Baga26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.